Skip to main content

DTIL

Stock
Health Care
Biotechnology

Performance overview

DTIL Price
Price Chart

Forward-looking statistics

Beta
1.68
Risk
83.02%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states.

Company info

SectorHealth Care
IndustryBiotechnology
Employees163
Market cap$84.5M

Fundamentals

Enterprise value-$904.4K
Revenue$51.1M
Revenue per employee—
Profit margin-42.99%
Debt to equity60.30

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$2.87
Dividend per share—
Revenue per share$6.48
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth+30.2
Credit-27.4
Liquidity-25.1
Inflation+28.7
Commodities+30.0
Interest Rates+2.5

Valuation

Dividend yield0.00%
PEG Ratio-0.64
Price to sales0.94
P/E Ratio-0.64
Enterprise Value to Revenue-0.02
Price to book0.93

Upcoming events

Next earnings dayMay 15, 2025
Next dividend day—
Ex. dividend day—

News

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates

Precision BioSciences (DTIL) came out with a quarterly loss of $2.21 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.35 per share a year ago.

Zacks Investment Research (May 15, 2025)
Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate

On Wednesday, Precision BioSciences, Inc. DTIL revealed initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level of the ELIMINATE-B trial.

Benzinga (February 19, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free